NCT03308214View on ClinicalTrials.gov

The Analysis of Factors Influencing the Vd of Imipenem in Septic Shock Patients

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

March 18, 2018

Primary Completion Date

December 28, 2018

Study Completion Date

December 28, 2018

Conditions
Septic Shock
Interventions
DRUG

Imipenem

Imipenem 1.0 q 8h

Trial Locations (1)

210009

Zhongda Hospital, Southeast University, Nanjing

All Listed Sponsors
lead

Southeast University, China

OTHER

NCT03308214 - The Analysis of Factors Influencing the Vd of Imipenem in Septic Shock Patients | Biotech Hunter | Biotech Hunter